Immunology of Head and Neck Cancer

Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal Cancer

1991 • 2,563 citations

Head and Neck Cancer

1993 • 2,263 citations

Cancer statistics, 1994

1994 • 1,345 citations

T and Tn, General Carcinoma Autoantigens

1984 • 998 citations

Regulation of the immune response by prostaglandins

1983 • 717 citations

Impaired immunologic reactivity and recurrence following cancer surgery

1970 • 668 citations

Epstein‐barr virus‐specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma

1976 • 644 citations

IL-12: Initiation Cytokine for Cell-Mediated Immunity

1993 • 583 citations

Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer

1982 • 448 citations

Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells.

1991 • 353 citations

Association of Overexpression of Tumor Suppressor Protien p53 With Rapid Cell Proliferation and Poor Prognosis in Node-Negative Breast Cancer Patients

1992 • 349 citations

Activation of Suppressor T Cells during Epstein-Barr-Virus-Induced Infectious Mononucleosis

1979 • 332 citations

The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot.

1992 • 283 citations

Cancer chemotherapy and biological response modifiers annual

1987 • 273 citations

Antitumor Activity and Immune Responses Induced by a Recombinant Carcinoembryonic Antigen-Vaccinia Virus Vaccine

1992 • 212 citations

Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer: A multivariate study of 492 cases

1992 • 211 citations

Selective inhibition of tumor cell growth by a recombinant single-chain antibody-toxin specific for the erbB-2 receptor.

1992 • 188 citations

Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant

1993 • 183 citations

Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA.

1993 • 180 citations

T-cell deficiency in patients with squamous cell cancer of the head and neck

1975 • 177 citations

Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin

1993 • 176 citations

Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck

1992 • 165 citations

The Murine Antitumor Immune Response and Its Therapeutic Manipulation

1984 • 164 citations

Prognostic significance of histologic host response in cancer of the larynx or hypopharynx

1971 • 164 citations

Sequential Increases in Proliferating Cell Nuclear Antigen Expression in Head and Neck Tumorigenesis: A Potential Biomarker

1993 • 158 citations

Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of lnterleukin-2 injected periiymphatically

1988 • 151 citations

Integrin expression in normal, hyperplastic, dysplastic, and malignant oral epithelium

1993 • 145 citations

Abnormalities of quantitative dinitrochlorobenzene sensitization in cancer patients: Correlation with tumor stage and histology

1973 • 143 citations

Regression of Head and Neck Carcinoma With a Prostaglandin-Synthesis Inhibitor

1981 • 139 citations

Altered expression in squamous carcinoma cells of an orientation restricted epithelial antigen detected by monoclonal antibody A9.

1986 • 139 citations

Antibodies to Epstein-Barr virus-related antigens in nasopharyngeal carcinoma. Comparison of active cases with long-term survivors.

1973 • 133 citations

Induction of alpha-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice.

1991 • 132 citations

The A9 Antigen Associated with Aggressive Human Squamous Carcinoma Is Structurally and Functionally Similar to the Newly Defined Integrin α6β4

1991 • 130 citations

Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck.

1987 • 129 citations

Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: Correlations with extent of tumor and prognosis

1986 • 126 citations

Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer.

1986 • 125 citations

Potentiation of human cell-mediated and humoral immunity by low-dose cyclophosphamide.

1984 • 124 citations

Monoclonal antibodies reactive with mucin expressed in breast cancer

1989 • 114 citations

Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: Effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 gene

1993 • 114 citations

Histiocytes in nasopharyngeal carcinoma in relation to prognosis

1986 • 114 citations

Evidence for local and systemic activation of immune cells by peritumoral injections of interleukin 2 in patients with advanced squamous cell carcinoma of the head and neck.

1993 • 112 citations

Natural Killer Cell Activity and Head and Neck Cancer: A Clinical Assessment<xref ref-type="fn" rid="FN2">2</xref>

1986 • 108 citations

Immunologic abnormalities in head and neck cancer

1974 • 105 citations

Altered Antigen Expression Predicts Outcome in Squamous Cell Carcinoma of the Head and Neck

1990 • 100 citations

Cytokine expression by head and neck squamous cell carcinomas

1992 • 99 citations

Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.

1993 • 95 citations

Antibodies to Herpesvirus Nonvirion Antigens in Squamous Carcinomas

1973 • 94 citations

Interleukin 1 regulates secretion of zinc-thymulin by human thymic epithelial cells and its action on T-lymphocyte proliferation and nuclear protein kinase C.

1992 • 93 citations

Prolonged depression of cellular immunity in cured laryngopharyngeal cancer patients treated with radiation therapy

1975 • 91 citations

Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response.

1987 • 91 citations

Prostaglandin-like material extracted from squamous carcinomas of the head and neck

1980 • 86 citations

Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck

1974 • 84 citations

Immunohistologic detection of lymphocyte subpopulations infiltrating in human oral cancer with special reference to its clinical significance

1984 • 82 citations

Excessive Prostaglandin E2 Production by Suppressor Monocytes in Head and Neck Cancer Patients

1982 • 82 citations

Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ.

1992 • 80 citations

The association of the IgA levels of serum and whole saliva with the progression of oral cancer

1975 • 79 citations

Prognostic factors for well‐differentiated squamous cell carcinoma in the oral cavity with emphasis on immunohistochemical evaluation

1993 • 77 citations

Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: In vitro restoration of this immunosuppression by thymic hormones

1993 • 76 citations

Immunologic assessment of regional lymph node histology in relation to survival in head and neck carcinoma

1976 • 75 citations

A randomized trial to evaluate the immunorestorative properties of synthetic thymosin-alpha 1 in patients with lung cancer.

1985 • 73 citations

HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx

1990 • 70 citations

MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck.

1993 • 70 citations

CIRCULATING LEVELS OF IMMUNOGLOBULIN E IN PATIENTS WITH CANCER

1972 • 69 citations

Immune complexes, serum proteins, cell-mediated immunity, and immune regulation in patients with squamous cell carcinoma of the head and neck

1986 • 68 citations

Immunologic evaluation and prognosis in patients with head and neck cancer

1977 • 67 citations

Immunobiologic Staging of Patients with Carcinoma of the Head and Neck

1983 • 67 citations

Lack of MHC class I antigens and tumour aggressiveness of the squamous cell carcinoma of the larynx

1990 • 63 citations

T-Cell Rosette Test in Squamous Cell Carcinoma of the Head and Neck

1976 • 62 citations

Antitumor activity of the single-chain immunotoxin BR96 sFv-PE40 against established breast and lung tumor xenografts.

1993 • 60 citations

Role of lymphocyte activation products (LAP) in cell-mediated immunity. II. Effects of lymphocyte activation products on lymph node architecture and evidence for peripheral release of LAP following antigenic stimulation.

1972 • 60 citations

Correlation of tumor burden with in vitro lymphocyte reactivity and antibodies to herpesvirus tumor-associated antigens in head and neck squamous carcinoma

1976 • 59 citations

Interleukins and Contrasuppression Induce Immune Regression of Head and Neck Cancer

1994 • 59 citations

Dinitrochlorobenzene Skin Sensitization and Peripheral Lymphocyte Count: Predictors of Survival in Head and Neck Cancer

1976 • 59 citations

Interleukin-2 injected around tumor-draining lymph nodes in head and neck cancer

1991 • 58 citations

Deficient cell‐mediated immunity in head and neck cancer patients secondary to autologous suppressive immune cells

1978 • 57 citations

Nutrition, immunity, and cancer-a review. Part I: Influence of protein or protein-calorie malnutrition and zinc deficiency on immunity.

1979 • 57 citations

Thymic endocrinology

1992 • 57 citations

Alterations in T-Lymphocyte Subpopulations in Patients With Head and Neck Cancer: Correlations With Prognosis

1987 • 56 citations

Loss of expression of blood group antigen h is associated with cellular invasion and spread of oral squamous cell carcinomas

1991 • 56 citations

Deficient immunity in head and neck cancer due to excessive monocyte production of prostaglandins.

1984 • 52 citations

Indomethacin sensitive suppressor cell activity in head and neck cancer patients pre- and postirradiation therapy

1982 • 52 citations

Prognostic significance of lymph node histology in patients with squamous cell carcinoma of the larynx, pharynx, or oral cavity

1976 • 51 citations

Phase I-II Study of Advanced Head and Neck Squamous Cell Carcinoma Patients Treated With Recombinant Human Interferon Gamma

1990 • 51 citations

Intensive recombinant interleukin-2 and alpha-interferon therapy in patients with advanced head and neck squamous carcinoma

1993 • 49 citations

T-cell adjuvants

1994 • 49 citations

Temporary regression of recurrent squamous cell carcinoma of the head and neck is achieved with a low but not with a high dose of recombinant interleukin 2 injected perilymphatically

1994 • 48 citations

Cellular immunity in patients with epidermoid cancer of the head and neck

1979 • 48 citations

Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.

1991 • 48 citations

Nutritional Status and General Immune Competence in Patients with Head and Neck Cancer

1981 • 47 citations

Clinical Results of Leukocyte Interferon-Induced Tumor Regression in Resistant Human Metastatic Cancer Resistant to Chemotherapy and/or Radiotherapy-Pulse Therapy Schedule

1985 • 47 citations

Deficient immunity in head and neck cancer due to excessive monocyte production of prostaglandins

1984 • 47 citations

The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer

1990 • 46 citations

Clinical and Immunopathological Results of a Phase II Study of Perilymphatically Injected Recombinant Interleukin-2 in Locally Far Advanced, Nonpretreated Head and Neck Squamous Cell Carcinoma

1991 • 45 citations

The extracellular domain of HER2/neu is a potential immunogen for active specific immunotherapy of breast cancer.

1990 • 45 citations

Squamous cell carcinoma antigen in the diagnosis and treatment follow-up of oral and facial squamous cell carcinoma

1990 • 45 citations

Zinc and copper levels in whole blood and plasma from patients with squamous cell carcinomas of head and neck

1979 • 44 citations

Lymphocyte Subpopulations and T-Cell Subsets in Human Oral Cancer Tissues: Immunohistologic Analysis by Monoclonal Antibodies

1984 • 44 citations

APPLICATION OF HUMAN LEUCOCYTE INTERFERON IN PATIENTS WITH TUMOURS OF THE HEAD AND NECK

1981 • 43 citations

Methotrexate plus bacillus Calmette-Guérin (BCG) and isoniazid in the treatment of cancer of the head and neck

1972 • 41 citations

Effects of Radiation Therapy on T‐Lymphocyte Subpopulations in Patients with Head and Neck Cancer

1985 • 41 citations

SCC‐RIA in the diagnosis of squamous cell carcinoma of the head and neck

1989 • 41 citations

Phase Ib Trial of the Effect of Peritumoral and Intranodal Injections of Interleukin-2 in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck: An Eastern Cooperative Oncology Group Trial

1994 • 40 citations

Immunobiologic Aspects of Head and Neck Cancer: Clinical and Laboratory Correlates

1991 • 40 citations

Immunostimulation of Patients With Head and Neck Cancer: In Vitro and Preliminary Clinical Experiences

1983 • 39 citations

Abnormal dinitrochlorobenzene skin sensitization: A prognostic sign of survival in head and neck squamous cell carcinoma

1973 • 38 citations

The doubtful relevance of nonspecific immune reactivity in patients with squamous cell carcinoma of the head and neck region

1983 • 37 citations

Fish lymphocytes respond to human IL-1.

1986 • 37 citations

Treatment of nasopharyngeal carcinoma with human leukocyte interferon.

1985 • 37 citations

HLA restriction and T‐cell‐receptor Vβ gene expression of cytotoxic T lymphocytes reactive with human squamous‐cell carcinoma of the head and neck

1994 • 36 citations

Lymphocyte phenotypes at tumor margins in patients with head and neck cancer

1987 • 36 citations

Human epidermal cells and squamous carcinoma cells synthesize a cytokine that augments natural killer cell activity.

1985 • 36 citations

DELAYED CUTANEOUS HYPERSENSITIVITY REACTIONS AND PROGNOSIS IN PATIENTS WITH CANCER

1976 • 35 citations

T-lymphocytes and Survival of Head and Neck Squamous Cell Carcinoma

1977 • 35 citations

Administration of a Prostaglandin Synthetase Inhibitor Associated With an Increased Immune Cell Infiltrate in Squamous Cell Carcinoma of the Head and Neck

1992 • 35 citations

Overexpression Of The A9 Antigen /A6βI Integrin In Head And Neck Cancer

1992 • 35 citations

Identification of inflammatory cell phenotypes in human oral carcinomas by means of monoclonal antibodies

1983 • 35 citations

Immunologic evaluation of patients with advanced head and neck cancer receiving weekly chemoimmunotherapy

1979 • 35 citations

Local Adoptive Immunotherapy of Advanced Head and Neck Tumors with Lak Cells and Interleukin-2

1990 • 35 citations

Defective Monocyte Chemotaxis in Patients With Head and Neck Cancer: Restoration After Treatment

1986 • 35 citations

Sera from patients with undifferentiated nasopharyngeal carcinoma contain a factor which abrogates specific epstein‐barr virus antigen‐induced lymphocyte response

1982 • 35 citations

Contribution of serum inhibitory factors and immune cellular defects to the depressed cell-mediated immunity in patients with head and neck cancer

1993 • 34 citations

Circulating IgA immune complexes in head and neck cancer, nasopharyngeal carcinoma, lung cancer, and colon cancer

1987 • 34 citations

Lymphokine Production and Lymphocyte Subpopulations in Patients With Head and Neck Squamous Carcinoma

1984 • 33 citations

HLA Class I and Class II Antigen Expression on Squamous Cell Carcinoma of the Head and Neck

1990 • 33 citations

An immunologic profile of young adults with head and neck cancer

1989 • 33 citations

Effect of low doses of interleukin-2 injected perilymphatically and peritumorally in patients with advanced primary head and neck squamous cell carcinoma.

1989 • 33 citations

Serum zinc, serum copper, and the Cu/Zn ratio in patients with epidermoid cancers of the head and neck

1980 • 33 citations

Gene Therapy of Cancer

1993 • 33 citations

Functional and Phenotypic Analysis of Lymphocytes in Head and Neck Cancer

1991 • 33 citations

Isoantigens A, B, and H in Morphologically Normal Mucosa and in Carcinoma of the Larynx

1977 • 32 citations

The Effect of Indomethacin on the Growth of Epidermoid Carcinoma of the Palate in Rats

1983 • 32 citations

Immunosuppressive substance in the sera of head and neck cancer patients

1988 • 32 citations

Adjuvant Trial of Levamisole in Patients With Squamous Cancer of the Head and Neck: A Preliminary Report

1979 • 32 citations

Inhibition of lymphokine-activated killer cell generation by blocking factors in sera of patients with head and neck cancer

1990 • 32 citations

Lymphokine-activated killer-cell function of lymphocytes from peripheral blood, regional lymph nodes and tumor tissues of patients with oral cancer

1989 • 31 citations

Immunobiology of head and neck cancer: Basic concepts

1979 • 31 citations

Viral-specific humoral immunity to herpes simplex-induced antigens in patients with squamous carcinoma of the head and neck

1976 • 30 citations

SQM1 Antiody defines a surface membrane antigen in squamous carcinoma of the head and neck

1985 • 30 citations

Phase I study of combination therapy with interleukin 2 and beta-interferon in patients with advanced malignancy.

1989 • 30 citations

Serum glycoproteins and immunoglobulins in nasopharyngeal carcinoma

1979 • 30 citations

Relationship of 4F2 antigen with local growth and metastatic potential of squamous cell carcinoma of the larynx

1990 • 30 citations

Interleukin-2, Cisplatin, and 5-Fluorouracil for Patients with Non-Small Cell Lung and Head/Neck Carcinomas

1991 • 30 citations

Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.

1977 • 30 citations

In situ hybridisation for cytokine gene transcripts in the solid tumour microenvironment

1993 • 30 citations

THE RELATIONSHIP OF CIRCULATING IgA TO CELLULAR IMMUNITY IN HEAD AND NECK CANCER PATIENTS

1988 • 29 citations

Successful tumour immunotherapy: possible role of antibodies to anti-inflammatory factors produced by neoplasms.

1985 • 29 citations

Immunohistochemical Detection of Retroviral—P15E—Related Material in Carcinomas of the Head and Neck

1987 • 29 citations

Cell‐mediated immune response in head and neck cancer patients

1976 • 28 citations

Mononuclear phagocyte function in head and neck cancer: Depression of murine macrophage accumulation by low molecular weight factors derived from head and neck carcinomas

1984 • 28 citations

Monoclonal Antibodies Reactive with the Breast Carcinoma-Associated Mucin Core Protein Repeat Sequence Peptide Also Recognise the Ovarian Carcinoma-Associated Sebaceous Gland Antigen

1990 • 28 citations

Correlation of Preoperative Immunologic Test Results with Recurrence in Patients with Head and Neck Cancer

1980 • 28 citations

Mononuclear phagocyte function in head and neck cancer. Chemotactic responsiveness of blood monocytes in correlation between histologic grade of the tumor and infiltration of these cells into the tumor area

1984 • 27 citations

Impairment of monocyte functions in advanced head and neck cancer

1988 • 27 citations

Major Immunoglobulin Ratios in Carcinoma of the Head and Neck

1978 • 27 citations

A correlative analysis of in vitro parameters of cellular immunity in patients with squamous cell carcinoma of the head and neck.

1977 • 27 citations

Levamisole in squamous cell carcinoma of the head and neck.

1979 • 27 citations

Comparison of in Vivo and in Vitro Prostaglandin E₂ Production by Squamous Cell Carcinoma of the Head and Neck

1994 • 26 citations

The ability of macrophages from head and neck cancer patients to kill tumor cells: Effect of prostaglandin inhibitors on cytotoxicity

1984 • 26 citations

Suppressor cells in the effector phase of autologous cytotoxic reactions in cancer patients

1988 • 25 citations

Prostaglandin E₂ of the Upper Aerodigestive Tract

1987 • 25 citations

Mononuclear phagocyte function in head and neck cancer: NBT‐dye reduction, maturation and migration of peripheral blood monocytes

1982 • 25 citations

Demonstration of Immunoglobulin in Tumor and Marginal Tissues of Squamous Cell Carcinomas of the Head and Neck 2

1977 • 25 citations

Assessment of immunocompetent cells in patients with head and neck squamous cell carcinoma.

1985 • 24 citations

Effect of interferon in therapy of skin and head and neck tumors

1981 • 24 citations

Immunologic patterns of regional lymph nodes in squamous cell carcinoma of the floor of the mouth

1985 • 24 citations

Stromal Reactions As Prognostic Factors In Epidermoid Carcinoma Of The Tongue

1973 • 24 citations

The effect of surgery on natural killer cell activity in head and neck cancer patients: In vitro reversal of a postoperatively suppressed immunosurveillance system

1985 • 24 citations

Definite vs Adjuvant Radiotherapy: Comparative Effects on Lymphocyte Subpopulations in Patients With Head and Neck Squamous Carcinoma

1985 • 24 citations

Unique immunobiological aspects of head and neck squamous carcinoma.

1975 • 24 citations

Serum immunoglobulins in squamous cell carcinoma of the oral cavity

1982 • 24 citations

T‐Cell Subpopulations in Head and Neck Carcinoma

1984 • 24 citations

The In Vivo Biologic Effect of Interleukin 2 and Interferon Alfa on Natural Immunity in Patients With Head and Neck Cancer

1990 • 23 citations

Depressed Natural Killer Cell Activity in Cervical Lymph Nodes Containing Focal Metastatic Squamous Cell Carcinoma

1988 • 23 citations

The Lack of Utility of a Tumor Marker Panel in Head and Neck Carcinoma: Squamous Cell Carcinoma Antigen, Carcinoembryonic Antigen, Lipid-Associated Sialic Acid, and CA-125

1992 • 23 citations

Radiotherapy and Head and Neck Cancer: Role of Lymphocyte Response and Clinical Stage

1980 • 23 citations

Indomethacin-induced augmentation of lymphoproliferative responses in patients with head and neck cancer

1986 • 23 citations

Update on immunology of head and neck cancer

1993 • 22 citations

Randomized clinical study on intratumoral BCG-cell wall preparation (CWP) therapy in patients with squamous cell carcinoma in the head and neck region

1981 • 22 citations

Assessment of Immunocompetent Cells in Patients with Head and Neck Squamous Cell Carcinoma

1985 • 21 citations

Association of IgA‐anti‐Fab autoantibodies with disease stage in head‐and‐neck cancer

1994 • 21 citations

An immunohistologic study of the distribution and status of activation of head and neck tumor infiltrating leukocytes

1987 • 21 citations

Interferon Gamma Induced Oncolysis: An Effect on Head and Neck Squamous Carcinoma Cultures

1988 • 20 citations

Mixed interleukins and thymosin fraction V synergistically induce T lymphocyte development in hydrocortisone-treated aged mice

1992 • 20 citations

Immunologic effector cells in head and neck cancer.

1992 • 20 citations

Identification of subsets of lymphocytes infiltrating head and neck tumor tissue: A preliminary report

1984 • 20 citations

The Effect of Preoperative Local Interleukin-2 (IL-2) Injections in Patients with Head and Neck Squamous Cell Carcinoma: An Immunological Study

1991 • 20 citations

Natural killer cell activity in patients with carcinoma of the larynx and hypopharynx

1985 • 20 citations

Infiltrating leukocyte populations and T-lymphocyte subsets in head and neck squamous cell carcinomas from patients receiving perilymphatic injections of recombinant interleukin 2. A pathologic and immunophenotypic study.

1990 • 20 citations

Interleukin-2 production in head and neck cancer patients

1985 • 19 citations

Intravenous, intralesional and endolymphatic administration of lymphokines in human cancer.

1986 • 19 citations

Intra-lymphatic administration of interleukin-2 (IL-2) in cancer patients: a pilot study.

1988 • 19 citations

Biological and prognostic implications of the morphologic aspects of immune reaction in lymph nodes draining head and neck cancers

1979 • 19 citations

Interferon activity and its characterization in the sera of patients with head and neck cancer

1984 • 18 citations

Comparison of retroviral p15E-related factors and interferon α in head and neck cancer

1994 • 18 citations

Evaluation of Therapeutic Potential of Interleukin 2- Expanded Tumor-Infiltrating Lymphocytes in Squamous Cell Carcinoma of the Head and Neck

1988 • 18 citations

Immune changes in peripheral blood resulting from locally directed interleukin-2 therapy in squamous cell carcinoma of the head and neck

1993 • 18 citations

Comparison of in vivo and in vitro prostaglandin E production by squamous cell carcinoma of the head and neck

1994 • 18 citations

Quantitation of Fc receptor-bearing T-lymphocytes (TG and TM) in oral cancer

1983 • 17 citations

Interleukin 2 Receptor Expression in Patients With Head and Neck Squamous Carcinoma: Effects of Thymosin 1 In Vitro

1989 • 17 citations

Serum tumor markers of head and neck cancer: Current status

1990 • 17 citations

Results of BCG adjuvant immunotherapy in 100 patients with epidermoid carcinoma of the head and neck

1977 • 17 citations

The usefulness of pretreatment DNCB in 85 patients with squamous cell carcinoma of the upper aerodigestive tract

1978 • 17 citations

Squamous cell carcinoma: infiltrating monocyte/macrophage subpopulations express functional mature phenotype

1990 • 16 citations

Basic science reviews: Immunomodulation therapy for squamous cell carcinoma of the head and neck

1993 • 16 citations

Tumor-infiltrating lymphoreticular cells. Histologic and immunohistologic investigations performed on metastasizing squamous cell carcinomas of the head and neck

1991 • 16 citations

Anti-squamous tumor antibodies in patients with squamous cell carcinoma.

1978 • 16 citations

T-Cell Subsets and Natural Killer Cell Function With Squamous Cell Carcinoma of the Head and Neck

1987 • 16 citations

Alaryngeal Speech and Development of an Internal Tracheopharyngeal Fistula

1980 • 16 citations

Lymphoid cells in lymph nodes and peripheral blood of patients with squamous cell carcinoma of the head and neck

1982 • 15 citations

Serum SCC-Ag in Head and Neck Squamous Cell Carcinoma

1990 • 15 citations

Immune restoration with interleukin-2 in patients with squamous cell carcinoma of the head and neck

1989 • 15 citations

T-Lymphocytes as a Prognostic Indicator in Head and Neck Cancer

1986 • 14 citations

Immunofluorescent Assessment of Tumour Infiltrating Cells in Laryngeal Carcinoma Application of Monoclonal Antibodies

1986 • 14 citations

Clinical trial of corynebacterium parvum (intra‐lymph‐node and intravenous) and radiation therapy in the treatment of head and neck carcinoma

1982 • 14 citations

Suppression of Cellular Immunity by Head and Neck Irradiation: Precipitating Factors and Reparative Mechanisms in an Experimental Model

1986 • 14 citations

ADJUVANT IMMUNO‐ AND/OR CHEMOTHERAPY WITH NEURAMINIDASE‐TREATED AUTOGENOUS TUMOR VACCINE AND BACILLUS CALMETTEGUÉRIN FOR HEAD AND NECK CANCERS*

1976 • 14 citations

Lymph node response and its relationship to prognosis in carcinomas of the head and neck

1987 • 14 citations

Mononuclear cell subsets in patients with oral cancer

1987 • 13 citations

[Adoptive immunotherapy by intra-arterial infusion of ATLAK or Allo-TLAK cells in patients with head and neck cancer].

1989 • 13 citations

Histamine type 2-receptor antagonists and cancer immunotherapy.

1990 • 13 citations

New Strategies of immunotherapy

1985 • 13 citations

Defective Monocyte Chemotaxis in Patients With Epidermoid Tumors of the Head and Neck

1985 • 13 citations

Tumor regression and temporary restoration of immune response after plasmapheresis in a patient with recurrent oral cancer

1987 • 13 citations

Nonspecific immunity and head and neck cancer: blastogenesis reviewed and revisited

1985 • 12 citations

The role of major histocompatibility complex expression on head and neck cancer cells in the induction of autologous cytotoxic T lymphocytes

1994 • 12 citations

Clinical trial of corynebacterium parvum (intra-lymph-node and intravenous) and radiation therapy in the treatment of head and neck carcinoma

1982 • 12 citations

Squamous Cell Carcinoma Antigen (SCC), Carcinoembryonic Antigen (CEA), and Tumour-Associated Trypsin Inhibitor (TATI) for Monitoring Head and Neck Cancer

1993 • 12 citations

Changes in the Ki-67 Labeling Rates of Head and Neck Squamous Cell Carcinomas during Preoperative Radiation Therapy

1992 • 12 citations

Natural cytotoxicity in draining lymph nodes of squamous cell cancer in the maxillofacial region

1987 • 11 citations

lnterleukin-2 mediated regulation of mitogen-activated T cell reactivity from different lymphoid sources in patients with squamous cell carcinoma of the oral cavity

1989 • 11 citations

Effect of IFN–γon the expression of MHC class I and class II antigens in a human malignant oral epithelial cell line

1991 • 11 citations

Local Administration Trials of Interleukin-2 for Head and Neck Cancer

1991 • 11 citations

Depressed pmnc blastogenic response in patients with cancer of the head and neck: A study of il‐2 production, il‐2 consumption, and il‐2 receptor expression

1989 • 10 citations

Phase II trial of carboplatin plus cisplatin in recurrent and advanced squamous cell carcinoma of the head and neck.

1991 • 10 citations

Recombinant interferon-gamma in the treatment of recurrent nasopharyngeal carcinoma.

1989 • 10 citations

Potential for targeting head and neck squamous cell carcinoma with monoclonal antibody K984

1992 • 9 citations

Detection of Regulatory Factors of Lymphokine-Activated Killer Cell Activity in Head and Neck Cancer Patients Treated with Interleukin-2 and Interferon Alpha

1992 • 9 citations

Epstein-Barr virus antibodies in patients with carcinoma of the nasopharynx and carcinoma of other sites in the head and neck

1975 • 9 citations

Interleukin-2 Release from Lymphocytes of Patients with Head and Neck Cancer

1989 • 9 citations

Serial studies of autologous antibody reactivity to squamous cell carcinoma of the head and neck

1992 • 9 citations

Mononuclear phagocyte function in head and neck cancer

1985 • 8 citations

Cellular localisation of tumour antigen (TA-4) in normal, dysplastic and neoplastic squamous epithelia of the upper aerodigestive tract

1990 • 8 citations

Role of levamisole immunotherapy as an adjuvant to radiotherapy in oral cancer. II. Lymphocyte subpopulations.

1988 • 8 citations

Detection and localization of tumor-associated immune components of head and neck squamous cell carcinomas.

1976 • 8 citations

Development of monoclonal antibodies with specificity to oral squamous cell carcinoma

1991 • 8 citations

Serum immunoglobulin E levels in patients with head and neck cancer

1988 • 8 citations

Inability of leukocytes to stimulate mixed leukocyte reactions.

1973 • 8 citations

Monoclonal antibody G6K12 specific for membrane‐associated differentiation marker of human stratified squamous epithelia and squamous cell carcinoma

1993 • 8 citations

Thymosin α1: Chemistry, Mechanism of Action and Clinical Applications

1993 • 8 citations

Head and Neck Tumor Immunology

1990 • 8 citations

Prognosis of lymphoma from a fine-needle aspirate

1993 • 8 citations

Immune defects in patients with head and neck cancer.

1993 • 8 citations

[A phase 2 study of recombinant interleukin 2 (S-6820) for head and neck cancer].

1990 • 7 citations

Prognostic Significance of Tissue Polypeptide Antigen (TPA) in Head and Neck Carcinomas

1993 • 7 citations

Isolation and purification of a squamous cell carcinoma of the head and neck-associated antigen identified by autologous antibody

1993 • 7 citations

Autologous tumor cell killing activity of tumor-associated lymphocytes in patients with head and neck carcinomas

1993 • 7 citations

Lymphokine‐activated killing of autologous and allogeneic short‐term cultured head and neck squamous carcinomas

1989 • 6 citations

Correlation of serum immune-reactive proteins with clinical tumor stage in patients with squamous carcinoma of the head and neck and nasopharyngeal carcinoma.

1979 • 6 citations

Immunomodulatory serum components in head and neck cancer

1993 • 6 citations

Localization of Mucinous - like Carcinoma Associated Antigen (MCA) in Breast Pathology: Comparison with Carcinoembryonic Antigen (CEA) and Tissue Polypeptide Antigen (TPA)

1990 • 6 citations

Perspectives of monoclonal antibodies for detection and treatment of head and neck tumours.

1993 • 6 citations

In vitro immune modulation by thymosin alpha₁ in patients with head and neck squamous cell carcinoma

1985 • 6 citations

Suppression of cellular immunity by head and neck irradiation

1988 • 6 citations

Monocytes and impaired leukocyte migration inhibitory factor production in head and neck squamous carcinoma

1988 • 5 citations

Characterization of Antibody-Forming Cells Adjacent to Laryngeal Carcinoma

1984 • 5 citations

REVIEW Head and neck tumour immunology

1988 • 4 citations

Combination Therapy with Thymosin α1 and Cytokines in the Treatment of Cancer and Infectious Diseases

1993 • 4 citations

Immunohistochemical localization of Leu‐M₁ carbohydrate antigen in human oral squamous cell carcinoma

1989 • 4 citations

Cytokines — The New Generation of Adjuvants for Vaccines?

1990 • 4 citations

Decreased sensitivity of T lymphocytes to normal adherent suppressor cells in patients with head and neck cancer.

1984 • 4 citations

Adjuvant Chemotherapy

1986 • 4 citations

Prognostic value of skin testing with dinitrochlorobenzene in patients with head and neck cancer.

1980 • 3 citations

Immunological status of patients in carcinoma head and neck.

1989 • 3 citations

Cytokine Synergy in Immunotherapy

1993 • 3 citations

Implication of Tumour Antigens and Immune Complexes in Laryngeal Cancer

1991 • 2 citations

Immunologic aspects of head and neck cancer.

1981 • 2 citations

Clinical and laboratory changes following plasmapheresis in 12 patients with squamous cancer of the head and neck.

1990 • 2 citations

Manual of otolaryngology—Head and neck therapeutics

1986 • 1 citations

Prospects for an Immunological Approach to Therapy of Ovarian Cancer

1994 • 1 citations

Manual of otolaryngology-head and neck therapeutics

1986 • 1 citations

Deleted Work

1955 • 0 citations